Product Code: RP-ID-10008198 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10008198
Market Overview:
Global Patient Registry Software Market Size, Growth, Opportunity and Forecast 2022-2030
"The Global Patient Registry Software market is anticipated to be valued at ~USD 2 billion in 2020 and is projected to grow at a CAGR of ~12% during the forecast period 2022-2030. The growing prevalence of chronic diseases such as cancer, diabetes and heart disease is driving the demand for integrated registries for better patient outcomes and drug production.
The adoption of electronic health records (EHR) is fueling the patient registration software market as regulators in developed countries rely on widespread implementation of electronic health record solutions in healthcare practice. Health care to improve health care. In Europe, the cost of patient enrollment programs for healthcare workers is projected to increase by 32.0% in 2018 over the past five years. Strict regulations on the adoption of electronic health records are driving the demand for patient registration software. For example, in May 2019, the Federal Health Minister drafted a bill on digital health solutions in Germany. This will help improve medical records, telemedicine infrastructure, and medical records implementation.
Most biotech and pharmaceutical companies are expected to see increased untapped opportunities due to increased investment in clinical trials. Patient enrollment data helps track patients for clinical trials. The data can also be used to identify locations infected with certain types of diseases. Pharmaceutical and medical device companies can greatly benefit from isolated medical records for monitoring over-the-counter drugs and medical devices. Patient enrollment helps reduce post-marketing research costs by generating and using realistic evidence.
Patient registration also helps develop new drugs, especially for rare diseases. Europe currently has over 700 rare disease (RDR) records and is actively involved in querying patient data, calculating sample sizes, and reducing sample sizes. It also makes it easy to monitor the use and results of specific medications between uses. For example, in June 2019, CloudPWR partnered with Accela to track prescription cannabis use. It helps to reduce drug use depending on the amount of the drug to reduce abuse. The above factors are expected to strengthen the patient registration software market in the coming years.
PRODUCT OVERVIEW :
On the basis of product, the patient registration software market is segmented into disease, healthcare, and product registration. The disease registration is divided into heart disease, diabetes, cancer, rare disease, asthma, etc. In 2020, disease registration services dominated the patient registration software market. Growing demand for integrative healthcare and decreasing disease burden are driving this sector. These records also help track patients in clinical trials for the production of new drugs.
Product registration is expected to increase profitability over the forecast period. When a medical or pharmaceutical device is approved by a regulatory body, registration is required for post-approval quality assessment to identify side effects and better understand the safety of the product. Government initiatives are driving the industry to support better patient outcomes.
For example, in April 2019 Northgate Public Services (NPS) in the UK partnered with the Indian Society of Hip and Knee Surgeons (ISHKS) to create the Joint Registry of India (IJP). It aims to establish and maintain the Common Indian Registry (IJR) to enable efficient and secure storage of patient information. The operating system is also designed to improve patient outcomes and provide insight into joint performance and long-term procedures.
INSIGHTFUL SOFTWARE :
Independent departments generated the most revenue in 2020 due to the ease of use of advanced tools and features in software. A standalone software application dedicated to specific data, such as heart disease, rare diseases, diabetes and cancer. patient data. So it is very accurate and data recovery is also very simple.
Additionally, the self-contained auto-update feature will help reduce additional IT costs and the consolidation segment is expected to grow significantly over the forecast period. The integrated system includes several programs that monitor affected geographic locations and evaluate clinical interventions across the country. It also helps to better understand the burden of the disease and the effectiveness of treatment programs. Integration, software add-ons and various aspects of add-ons are designed to work flawlessly to drive the growth of the patient registration software market.
DISTRIBUTION MODEL OVERVIEW
In the distribution model, households recorded the largest revenue in 2020 due to data security, discoverability, and accessibility. It is also useful for transferring large data files and system updates. The priority of these services is primarily full access to information and control within the building. Pharmaceutical companies and research institutions often prefer in-house data privacy solutions and customer-specific service options, while web/cloud solutions are planned for advanced features such as real-time monitoring. and remote access to data.
Also, integration according to standard guidelines is another requirement for this solution. Today, public and private organizations are choosing cloud-based software over enterprise hardware. For example, in November 2019, Google partnered with Ascension Medical Systems to analyze data from millions of patients at approximately 150 hospitals in the District of Columbia and store it on cloud computing systems.
DATABASE TYPE OVERVIEW :
In 2020, the business segment dominated the patient registration software market owing to its superior data security compared to public databases. These databases are compliant with government and cryptographic standards and are increasingly in demand. Additionally, the software provides two features: contact for business issues, timely software updates, and ease of use.
The commercial system allows for the exchange of data between government research institutions such as the CDC and the Central Registry of Diseases, driving the growth of the industry, and enables a public database of the kind expected to improve profitability over the forecast period. This is due to the increase in the number of research institutions. This database is used for specific research projects or projects driving demand. Also, there are no copyrights or voluntary patents on this software. Registry Plus, for example, is a public database registry launched by the CDC in 2014 to collect and process cancer data for specific projects.
JOB INFORMATION:
On the basis of performance, the Ministry of Health dominated the patient registration software market in 2020. Cost of Service (FFS) has changed as stakeholder demand for solutions that support value-based care delivery has increased. Value-based model (VBP). PHM standardizes healthcare approaches, improves clinical outcomes, reduces disease management costs, accelerates industry growth, and supports the medical research and clinical trials industry over the forecast period.
It should show the fastest growth. These records usually store data about patients with health problems. These drugs may contain patient health information about certain treatments to help develop new drugs. The Nursing Patient Recording Software market has great potential with real-time cost-effective data. The above market factors are expected to enhance the capabilities of patient registration software with endless possibilities.
END USE APPLICATION:
On the basis of end-use application, the patient registration software market is segmented into public and outpatient services, hospitals and medical practices, private taxpayers, pharmaceutical and medical device companies, and research institutions. The state and tertiary sectors had the highest earnings in 2020. The growth of the software market is expected to accelerate as governments implement disease burden reduction programs in developed and developing countries. Patient enrollment beyond expectations.
REGIONAL OUTLOOK:
North America led the global patient registration software market in terms of revenue sharing in 2020. The growth of the target population along with the increasing prevalence of disease and the need for population-based data is driving the market growth of the region.
Additionally, growing government initiatives have made this sector a major contributor to the patient registration software market. To make recording software users more user-friendly and relevant to clinical research, the company is constantly working to create better interactive software for users. For example, IQVIA launched a new web-based clinical trial data solution in August 2019 and the Asia Pacific region is expected to experience profitability growth over the forecast period.
The proliferation of electronic health records has increased in recent years. Increasing pressure to reduce neglect, frequent visits, increase in diagnostic errors, increase in comorbidities and aging are the most important drivers of the market in this segment. Additionally, government-funded initiatives are accelerating the growth of the patient registration software market, especially in Japan, China and South Korea. For example, in May 2018, the South Korean government invested $33.4 million to develop an artificial intelligence system that analyzes a patients medical history for better diagnosis and treatment options. In 2019, Fujifilm built a Fujifilm VET system in Japan and entered the regional cancer recording software market.
PATIENT REGISTRATION SOFTWARE MARKET SHARE INSIGHTS:
This industry is characterized by the presence of various large and small industry players. The patient registration software market is highly competitive and highly fragmented. Some of the major market participants include Phytel, Inc.; Maxson; Quintiles; Dasima Software; ImageTrend, Inc.; IBM; Akvia. Players continue to participate in strategic initiatives such as geographic expansion, government cooperation, new product launches, and mergers and acquisitions to achieve deeper penetration. For example,
In July 2019, Pulse Infoframe collaborated with Immunocore to launch the first uveal melanoma patient registry. This is a joint effort of commercial and academic institutions in the United States, Australia, and the United Kingdom. The knowledge gained through the patients academic records is expected to better understand the disease and contribute to future clinical research. In March 2019, Amplitude Clinical released Amplitude software, which is pre-installed with patient records, which involves fine-tuning the case mix to improve diagnosis and treatment procedures.
MARKET SEGMENTS COVERED BY THE REPORT;
The report forecasts global, regional and national revenue growth, and analyzes the latest industry trends in each sub-segment from 2022-2030. For the purpose of this research, Kenneth Research will report on the global patient record software market based on product, software, database type, deployment model, function, end use, and region: Product Outlook (Revenue, USD million, 2022-2030). Vascular Disease Registration Diabetes Cancer Rare Disease Asthma Other Health Service Registration Product Registration Medical Device Drug Software Outlook (Revenue, USD million, 2022-2030) Outlook of Independent Integrated Deployment Model (Revenue, USD million, 2022-2030) Internal deployment Web/based Cloud type outlook data (revenue, millions of dollars, 2022-2030) commercial public function outlook (income, millions of dollars), 2022-2030) population health management health information exchange patient care management h & clinical research product results evaluation end use Prospects (revenue, millions of dollars, 2022-2030) Government and third-party hospitals and doctors; offices private payers pharmaceutical and medical device companies research institutions. "
1. Phytel, Inc. (An IBM Corporation Company)
2. Image Trend, Inc.
3. FIGmd, Inc.
4. Liaison Technologies
5. Cecity.Com, Inc. (A Premier, Inc. Company)
6. Dacima Software, Inc.
7. Global Vision Technologies, Inc. (GVT)
8. Ifa Systems AG
9. Inc Research Holdings, Inc.
10. M2S, Inc. (A Medstreaming Company)
11. McKesson Corporation
12. Quintiles IMS Holdings, Inc.
13. Optum, Inc. (A Part of Unitedhealth Group, Inc.)
14. EVADO Pty. Ltd.
15. Velos, Inc.
Related Reports
Proof of Quality & Reliability
